Catalyst Wire Dossier Catalyst Wire Dossier

Refortrix

Tdap · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Refortrix, covering 2019-10-01 to 2019-10-01. Get the full timeline:

Most recent: Clinical Trial Update: A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.

See pricing